Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Prevalence of cardiovascular disease and evaluation of standard of care in type 2 diabetes: a nationwide study in primary care

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. RNA oxidation and albuminuria in type 1 diabetes patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Discontinuation of diabetes medication in the 10 years before death: a nationwide register-based study: 21-25 September 2020.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  3. Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Effects of β-hydroxybutyrate on cognition in patients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Objective: Cardiovascular disease (CVD) complicates type 2 diabetes. Empagliflozin and liraglutide have demonstrated improved survival in patients with type 2 diabetes and established CVD. We assessed prevalence and standard of care of patients with type 2 diabetes and established CVD managed in primary care.

Patients and methods: A total of 129 general practitioners in both rural and urban areas, responsible for 348 373 patients, identified their patients with type 2 diabetes. The identification was based on a search for International Classification of Primary Health Care 2 codes in the general practitioners' electronic patient record systems. Patients with concomitant CVD were identified and characterized.

Results: A total of 17 113 (4.9%) patients were diagnosed with type 2 diabetes. Type 2 diabetes with concomitant CVD was found in 3665 (21.4%) patients, with their mean age being 72 years, and 34.6% were women. Mean estimated glomerular filtration rate was 68.2 ml/min, and 22.2% had microalbuminuria or macroalbuminuria. Standard of care was fair: mean glycated hemoglobin was 52.3 mmol/mol (Diabetes Control and Complications Trial=6.9%), mean blood pressure was 131.4/75.7 mmHg, and mean low-density lipoprotein cholesterol was 2.0 mmol/l.

Conclusion: In a nationwide database survey in primary care, the prevalence of CVD in patients with type 2 diabetes was high (21.4%). Standard of care was largely in accordance with national guidelines. Identification of eligible patients is possible with existing electronic patient record systems. Identifying this high-risk subgroup of patients with type 2 diabetes and optimizing their treatment might add further cardiovascular benefits as suggested by recent cardiovascular outcome trials.

Original languageEnglish
JournalCardiovascular Endocrinology
Volume6
Issue number4
Pages (from-to)145-151
Number of pages7
ISSN2162-688X
DOIs
Publication statusPublished - Dec 2017

    Research areas

  • Journal Article

ID: 52781183